Quick Overview: Hear from Carlos Sattler, VP of Clinical Development & Medical Affairs; Julia Pike, SVP of Intellectual Property; Cindy Cao, ... Markus Hartmann, PhD, from European Consulting & Contracting in Oncology, Trier, Germany, discusses the This video provides a high-level overview of the regulatory
Biosimilars Approval Process - Detailed Overview & Context
Hear from Carlos Sattler, VP of Clinical Development & Medical Affairs; Julia Pike, SVP of Intellectual Property; Cindy Cao, ... Markus Hartmann, PhD, from European Consulting & Contracting in Oncology, Trier, Germany, discusses the This video provides a high-level overview of the regulatory In the totality-of-the-evidence approach, FDA considers all the available evidence needed to make a regulatory decision about a ... In this episode of Biotech Stage Podcast, Arun Singhal sits down with Jake Knurek, Business Development expert at Mabion, one ...
